Douglas Whittington

Company: Tango Therapeutics, Inc.

Job title: Executive Director - Biochemistry

 

Seminars:

Structure-Guided Drug Design of MTA-Cooperative PRMT5 Inhibitors 1:30 pm

day: Day 2

Panel Discussion: Bridging Medicinal & Computational Chemistry with Structural Insights for Smarter Drug Design 2:00 pm

  • Overcoming challenges in integrating structural and computational approaches to advance from target identification to lead development
  • Real-world success stories and lessons learned from projects were collaboration between disciplines significantly improved drug candidates
  • Strategies for future-proofing drug discovery pipelines by embedding structural insights into medicinal and computational chemistry workflows

day: Day 1

Douglas Whittington